Hansa Biopharma AB, ("Hansa" or "the Company"), , today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imlifidase. The Company is ...
Two weapons, one mission set, one ballistic brain: the M7 and M250 were built to fight as a paired system so squads can put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback